.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020402

« Back to Dashboard
NDA 020402 describes ADVIL MIGRAINE LIQUI-GELS, which is a drug marketed by Pfizer and is included in one NDA. It is available from three suppliers. Additional details are available on the ADVIL MIGRAINE LIQUI-GELS profile page.

The generic ingredient in ADVIL MIGRAINE LIQUI-GELS is ibuprofen. There are sixty-three drug master file entries for this compound. Two hundred and forty-three suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for NDA: 020402

Tradename:
ADVIL LIQUI-GELS
Applicant:
Pfizer
Ingredient:
ibuprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020402

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL LIQUI-GELS
ibuprofen
CAPSULE;ORAL 020402 NDA Pfizer Consumer Healthcare 0573-0149 0573-0149-13 1 BOTTLE in 1 CARTON (0573-0149-13) > 80 CAPSULE, LIQUID FILLED in 1 BOTTLE
ADVIL LIQUI-GELS
ibuprofen
CAPSULE;ORAL 020402 NDA Pfizer Consumer Healthcare 0573-0168 0573-0168-20 1 BOTTLE in 1 CARTON (0573-0168-20) > 20 CAPSULE, LIQUID FILLED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrengthEQ 200MG FREE ACID AND POTASSIUM SALT
Approval Date:Apr 20, 1995TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrengthEQ 200MG FREE ACID AND POTASSIUM SALT
Approval Date:Mar 16, 2000TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc